Nordson Corporation (NDSN)

NASDAQ: NDSN · USD

$326

+1.23 (+0.4%)· Recorded snapshot

Respaldo en inglésES

Mostrando la fuente en inglés mientras traducimos

Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

StockMarketAgent Research · Analyzed 2026-10-11

Our latest published analysis: NDSN rated Sell

Nordson Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$207 / share

Potential value

$256 / share

Upside to FV

-37.0%

from $326

Moat

8.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$18.3B
Revenue (ttm)	3B
Net income (ttm)	555.2M
EPS (ttm)	$9.89
Shares out	55.7M
P/E (trailing)	32.9x
P/E (forward)	24.8x
Dividend	$3.76 (1.16%)
Volume	181,485
Beta	0.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): 555.2M
EPS (ttm): $9.89
P/E (trailing): 32.9x
P/E (forward): 24.8x
Market cap: $18.3B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-10-31	2022-10-31	2023-10-31	2024-10-31	2025-10-31	Trend
Revenue	$2.36B	$2.59B	$2.63B	$2.69B	$2.79B	+4.3%
Gross profit	$1.32B	$1.43B	$1.43B	$1.49B	$1.54B	+3.8%
Operating income	$615.1M	$702.4M	$672.8M	$674.0M	$711.7M	+3.7%
Net income	$454.4M	$513.1M	$487.5M	$467.3M	$484.5M	+1.6%
EPS (diluted)	$7.74	$8.81	$8.46	$8.11	$8.51	+2.4%
EBITDA	$703.6M	$771.6M	$786.7M	$810.6M	$849.3M	+4.8%
R&D	$59.4M	$52.5M	$71.4M	$65.0M	$68.2M	+3.5%
SG&A	$709.0M	$724.2M	$752.6M	$812.1M	$815.5M	+3.6%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Vender
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Reducir
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Mantener
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	Mantener
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	Mantener
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	Mantener

Base and Bull scenarios

Base60%

Price target

$206.83

-37.0% from spot

The Base scenario carries a probability of 60.0% and establishes a target valuation of $206.83, implying a projected return of -37.0% relative to $328.17. This path assumes that precision dispensing demand remains steady across industrial manufacturing and that order backlog converts cleanly over an operational turnover horizon without supply disruptions. Operating margins expand gradually as operational efficiencies under NBS Next offset moderate price and cost pressures. Disconfirmation would emerge if quarterly order intake slows or if incremental margins fail to meet management expectations, signaling competitive share losses or end-market softening.

Precision dispensing demand remains stable across core automotive and industrial assembly lines
Order backlog converts into recognized shipments across normal operational manufacturing turnover periods
Continuous operational efficiency initiatives under NBS Next offset moderate input cost inflation and preserve pricing

Bull20%

Price target

$255.82

-22.0% from spot

The Bull scenario represents a probability of 20.0% with a target valuation of $255.82, yielding an implied return of -22.0% against $328.17. In this trajectory, an extended semiconductor advanced packaging investment cycle accelerates high-margin equipment shipments in Advanced Technology Solutions, while medical fluid component adoption accelerates. Operating margins expand robustly as strong operating leverage delivers incremental margins at the top end of management targets. Disconfirmation of this optimistic path would occur if electronics packaging orders plateau or if customer capital expenditure budgets tighten across key manufacturing regions.

Semiconductor advanced packaging capital equipment investment expands across global manufacturing facilities
Operating leverage drives consolidated incremental margins toward the high end of management expectations
Medical fluid solutions sustain above-market organic expansion through continuous single-use component adoption

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($206.83). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
8.3%	$221	$226	$231	$236	$242
8.8%	$210	$214	$218	$222	$227
9.3%	$200	$204	$207	$210	$214
9.8%	$192	$194	$197	$200	$204
10.3%	$184	$186	$189	$191	$194

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E24.8

P25 n/aP50 n/aP75 n/a

Trailing P/E33.2

P25 n/aP50 n/aP75 n/a

ROE17.8

P25 n/aP50 n/aP75 n/a

ROIC13.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NDSN indicators

Market & fundamental data

Available fields

293

Groups with data

Currency

USD

Showing 293 of 293 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000072331
Company name	Nordson Corporation
Country	United States
Country code	US
CUSIP number	655663102
Earnings date	2026-12-09
Earnings time	amc
Employees	8,200
Employees change	500
Employees growth	6.49%
Enterprise value	$19.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	October
Founded	1935
In index	SP500
Industry	Specialty Industrial Machinery
Is primary listing	Yes
Is SPAC	No
ISIN number	US6556631025
Last 10-K release date	2025-12-17
Last earnings date	2026-08-19
Last refreshed	2026-10-28
Last stock split date	2011-04-13
Last stock split type	Forward
Market cap	$18.1B
Market cap category	Large-Cap
Next earnings date	2026-12-09
Options	Yes
Price	$325.54
Price currency	USD
Sector	Industrials
SIC code	3569
Stock price date	2026-10-28
Symbol	NDSN
U.S. state	Ohio
Website	https://www.nordson.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	28.28x
Average P/E ratio (10Y)	27.82x
Average P/E ratio (3Y)	28.36x
Average P/E ratio (5Y)	27.96x
Earnings yield	3.04%
EV/Earnings	35.71x
EV/EBIT	24.46x
EV/EBITDA	20.7x
EV/FCF	27.38x
EV/Sales	6.65x
FCF / EV yield	3.65%
FCF yield	4%
Forward EV/Sales	6.26x
Forward P/E	25.73x
Forward P/S	5.72x
Graham number	114.26892
Graham upside	-64.87%
Industry forward P/E	24.96x
Industry P/E	31.67x
Lynch fair value	$88.06
Lynch upside	-72.93%
P/(FCF - SBC) ratio	25.86x
P/(OCF - SBC) ratio	24.15x
P/B ratio	5.53x
P/E ratio	32.92x
P/FCF ratio	25.03x
P/OCF ratio	23.43x
P/S ratio	6.08x
PEG ratio	1.97x
Price/EBITDA ratio	18.92x
Sector forward P/E	26.24x
Sector P/E	40.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	27.2%
EBITDA margin	32.15%
Effective tax rate	17.69%
FCF margin	24.3%
Gross margin	55.39%
Operating margin	27.2%
Pretax margin	22.64%
Profit margin	18.63%
Profit per employee	$67,705
Profitable quarters	67
Profitable years	16
Revenue per employee	$363,390
ROA	8.47%
ROA (5Y)	9.19%
ROCE	15.53%
ROE	17.76%
ROE (5Y)	19.86%
ROIC	13.28%
ROIC (5Y)	14.69%
SBC / revenue	0.78%
Tax / revenue	4%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	24.36%
EPS growth (Q)	22.97%
EPS growth (QoQ)	30.62%
EPS growth 10Y	8.83%
EPS growth 3Y	4.43%
EPS growth 5Y	9.88%
EPS growth quarters	5
EPS growth years	1
FCF growth	33.33%
FCF growth (Q)	4.57%
FCF growth (QoQ)	38.86%
FCF growth 3Y	5.58%
FCF growth 5Y	6.62%
Gross profit growth	8.1%
Gross profit growth (Q)	11.61%
Gross profit growth 3Y	5.53%
Gross profit growth 5Y	5.06%
Net income growth	22.02%
Net income growth (Q)	21.52%
Net income growth (QoQ)	30.29%
Net income growth 3Y	3.48%
Net income growth 5Y	8.91%
Net income growth quarters	5
Net income growth years	1
OCF growth	26.24%
OCF growth (Q)	4.79%
OCF growth (QoQ)	38.02%
OCF growth 10Y	10.33%
OCF growth 3Y	5.88%
OCF growth 5Y	6.37%
Operating income growth	15.64%
Operating income growth (Q)	11.5%
Operating income growth 3Y	4.3%
Operating income growth 5Y	6.82%
Revenue growth	7.02%
Revenue growth (Q)	10.27%
Revenue growth (QoQ)	10.37%
Revenue growth 10Y	5.49%
Revenue growth 3Y	4.75%
Revenue growth 5Y	5.12%
Revenue growth quarters	6
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-49.4M
Depreciation and amortization	$147.5M
EBIT	$810.4M
EBITDA	$957.9M
EPS	$9.89
FCF per share	$13.00
Financing cash flow	$-772.6M
Free cash flow	$724M
Free cash flow minus SBC	$700.8M
Gross profit	$1.7B
Income taxes	$119.3M
Investing cash flow	$-37.4M
Net borrowing	$-394.9M
Net cash flow	$-34.4M
Net income	$555.2M
Operating cash flow minus SBC	$750.2M
Operating income	$810.4M
Revenue	$3B
Stock-based compensation	$23.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.47
Book value per share	$58.69
Debt / EBITDA	1.85
Debt / equity	0.56
Debt / FCF	2.51
Goodwill	$3.3B
Interest coverage	8.94
Long-term assets	$4.6B
Long-term liabilities	$2B
Net cash (debt)	$-1.7B
Net cash / market cap	-9.41%
Net debt / EBITDA	1.78
Net debt / equity	0.52
Net debt / FCF	2.35
Piotroski F-Score	8
Property, plant and equipment	$582.4M
Shareholders' equity	$3.3B
Tangible book value	$-673.1M
Tangible book value per share	$-12.08
Total assets	$5.9B
Total cash	$113.9M
Total debt	$1.8B
Total liabilities	$2.7B
WACC	9.19%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	$1.3B
Current liabilities	$728.5M
Current ratio	1.82
Inventory turnover	2.86
Net working capital	$712.6M
Quick ratio	1.05
Working capital	$599.4M
Working capital turnover	5.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.83%
Dividend growth	7.59%
Dividend growth (10Y)	13.13%
Dividend growth (3Y)	8.94%
Dividend growth (5Y)	15.14%
Dividend growth years	63
Dividend payment date	2026-10-02
Dividend payment years	63
Dividend payout frequency	Quarterly
Dividend per share	$3.76
Dividend yield	1.16%
Ex-dividend date	2026-09-10
FCF payout ratio	28.93%
Last dividend	$0.94
Payout ratio	38.03%
Shareholder yield	2.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	226.72%
10Y return CAGR	13.77%
10Y total return	263.14%
150-day SMA	$299.44
15Y price change	578.35%
15Y return CAGR	14.84%
15Y total return	696.51%
1D price change	0.38%
1M price change	-0.07%
1M total return	-0.07%
1W price change	-1.81%
1W total return	-1.81%
1Y price change	36.58%
1Y return CAGR	38.31%
1Y total return	38.28%
20-day SMA	$327.33
200-day SMA	$294.46
20Y price change	1,326.56%
20Y return CAGR	15.54%
20Y total return	1,697.1%
3M price change	9.47%
3M total return	9.79%
3Y price change	53.46%
3Y return CAGR	16.81%
3Y total return	59.4%
50-day SMA	$323.31
50-day SMA vs 200-day SMA	50over200
52-week high	$339.12
52-week high date	2026-08-26
52-week low	$223.29
52-week low date	2025-11-19
5Y price change	30.62%
5Y return CAGR	6.74%
5Y total return	38.53%
6M price change	14.86%
6M total return	15.53%
After-hours change	2.11%
After-hours close	$325.54
After-hours price	$332.41
All-time high	$339.12
All-time high date	2026-08-26
All-time low	$3.75
All-time low date	1985-10-31
Average true range (ATR)	$6.83
Average volume	348.2K
Beta (1Y)	0.46
Beta (2Y)	0.99
Beta (5Y)	0.99
Change from 52-week high	-4%
Change from 52-week low	45.79%
Change from all-time high	-4%
Change from all-time low	8,581.07%
Change from open	0.29%
Day's gap	0.1%
Dollar volume	$59.1M
High price	$325.80
Low price	$323.61
Monthly RSI	68.31
Open price	$324.61
Position in 52-week range	88.13%
Premarket change	0%
Premarket close	$324.30
Premarket price	$324.30
Previous close	$324.30
Price vs 150-day SMA	8.72%
Price vs 20-day SMA	-0.55%
Price vs 200-day SMA	10.56%
Price vs 50-day SMA	0.69%
Relative volume	0.52
RSI	51.56
Sharpe ratio	1.39
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	0.24
Sortino ratio	2.53
Sortino ratio (3Y)	1.13
Sortino ratio (5Y)	0.56
Volume	181.5K
Weekly RSI	61.19
YTD price change	35.4%
YTD total return	36.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52.5M
Float percentage	94.22%
Shares change (QoQ)	-0.13%
Shares change (YoY)	-1.83%
Shares held by insiders	5.64%
Shares held by institutions	77.63%
Shares outstanding	55.7M
Short % of float	2.76%
Short % of shares	2.6%
Short ratio	4 days

Deeper analysis on NDSN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this NDSN report

What is the latest published NDSN stock rating?

Nordson Corporation is shown with Sell in the latest published report, analyzed 2026-10-11. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NDSN analysis?

The full latest published report, analyzed 2026-10-11, lives at /stocks/NDSN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for NDSN?

The latest published report analyzed 2026-10-11 gives NDSN a fair value of USD 207 and a potential value of USD 256. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the NDSN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-11). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

SellNDSN · Fair value $207-37.0%

Read full analysis →

Nordson Corporation (NDSN)

Our latest published analysis: NDSN rated Sell

Price

Financial snapshot

Fair-value bridge

Latest news · NDSN

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All NDSN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NDSN

Frequently asked questions

Historial de calificaciones

Category	Score	Reading
Valuation	1.5
Management	9.5
Balance Sheet	7.0
Profitability	6.5
Revenue Growth	6.0
Risk Assessment	6.5
Competitive Moat	8.5
Earnings Quality	9.0
Capital Efficiency	6.5